What it is

Andromeda Protocol is the broad end of the range: five peptides drawn from five separate literatures, five vials in one box. It spans receptor and mitochondrial signalling, the growth-hormone axis, and the skin, connective-tissue and tissue-repair domains.

What's inside

• Retatrutide 40mg→A 39-amino-acid agonist at the GLP-1, GIP and glucagon receptors, studied for appetite-regulatory signalling and energy-substrate handling.
• MOTS-c 40mg→A 16-amino-acid peptide encoded in mitochondrial DNA, studied for AMPK activation and cellular energy metabolism.
• Tesamorelin 20mg→A 44-amino-acid GHRH analogue, studied for visceral-adipose dynamics and IGF-1 signalling.
• GHK-Cu 50mg→A copper-binding tripeptide, studied in skin and connective-tissue research for its role in collagen and matrix signalling.
• BPC-157 + TB-500 20mg→A 15-amino-acid gastric peptide paired with a thymosin beta-4 fragment, the standard pairing of the tissue-repair literature.

What it does for you

• Incretin and glucagon receptor signalling. Retatrutide engages three receptors at once, and that combination is why the metabolic literature treats it as a class apart from single-receptor agonists.
• Mitochondrial energy metabolism. MOTS-c is encoded inside the mitochondrion itself and activates AMPK, the sensor cells use to read their own energy balance.
• Visceral-adipose dynamics. Tesamorelin holds a longer signal at the pituitary GHRH receptor, and the published work follows what that extended signal does across visceral adipose tissue and IGF-1.
• Skin, connective tissue and repair. GHK-Cu carries a copper ion into collagen and matrix signalling, while BPC-157 with TB-500 is the pairing the tissue-repair literature has studied most.

Good to know